Hui Peng, M.D., Ph.D.

Titles

Professor

Vice Director of Division of Nephrology, Department of Medicine, the Third Affiliated Hospital of Sun Yat-sen University

Research Interests

??????? Diabetic kidney disease

??????? Protein-energy wasting in chronic kidney disease

??????? The peritoneal fibrosis mechanism in Peritoneal dialysis

?

Education and Experience

Education

??? M.D. 1992~1997, Sun Yat-sen University, Zhongshan School of Medicine, Guangzhou, P.R. China

??? M.S. 1997~1999, Sun Yat-sen University, College of Graduate Studies, Guangzhou, P.R. China

??? Ph.D. 2001~2004, Sun Yat-sen University, College of Graduate Studies, Guangzhou, P.R. China

Postdoctor fellowship, 2005~2007, Division of nephrology and hypertension, Northwestern University, Feinberg school of Medicine, Chicago, USA

Visiting scholar, 2014~2015, Division of nephrology and hypertension, Baylor College of Medicine, Houston, Texas, USA

?

Experience

Residency (1999-2001), Division of nephrology, Department of Medicine, the third affiliated hospital of Sun Yat-sen University, Guangzhou, P.R. China

Attending physician (2003-2008), Division of nephrology, Department of Medicine, the third affiliated hospital of Sun Yat-sen University, Guangzhou, P.R. China

Associate professor (2008-2014 ), Division of nephrology, Department of Medicine, the third affiliated hospital of Sun Yat-sen University, Guangzhou, P.R. China

??? Professor (2005- ), Division of nephrology, Department of Medicine, the third affiliated hospital of Sun Yat-sen University, Guangzhou, P.R. China

?

Honors and Awards

Dr. Peng is a young member of the standing committee of Chinese Medical Doctor Association, Nephrologists Branch, member of standing committee of Guangdong Medical Association，Kidney Disease Branch. She is also an invited reviewer of Chinese Journal of Nephrology, an editor of American Journal of Kidney Disease （Chinese version）.

?

Publications

1.??????? Peng H, Li Y, Wang C, Zhang J, Chen Y, Chen W, Cao J, Wang Y, Hu, Z, Lou, T. ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy. Sci Rep. 2016; 6: 20304.

2.??????? Peng H, Cao J, Yu R, Danish F, Wang Y, Mitch WE, Xu J*, Hu Z*. CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation,J Am Soc Nephrol,2015,27(2):509-519。

3.??????? Peng H, Luo P, Li Y, Wang C, Liu X, Ye Z, Li C, Lou T*. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. PLoS One. 2013; 8(11):e80009.

4.??????? Peng H,?Chen WF,?Wu C,?Chen YR,?Peng B,?Paudel SD,?Lou TQ.Culture-negative subacute bacterial endocarditis masquerades as granulomatosis with polyangiitis (Wegener's granulomatosis) involving both the kidney and lung. BMC Nephrol.?2012 Dec 26; 13(1):174. [Epub ahead of print]

5.??????? Hui Peng, Cheng Wang, Zeng-chun Ye, et al. How increased VEGF induces glomerular hyperpermeability: a potential signaling pathway of Rac1 activation. Acta Diabetol. 2009, 47, S1, 57-63.

6.??????? Vasantha Kolavennu, Lixia Zeng, Hui Peng, Yin Wang, and Farhad R. Danesh. Targeting of RhoA/ ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose Control. Diabetes. 2008 Mar; 57(3):714-23. 2008; 57(3):714-23.

7.??????? Xu H, Zeng L, Peng H, Chen S, Jones J, Chew TL, Sadeghi MM, Kanwar YS, Danesh FR. Mevalonate depletion prevents VEGF-induced “Inside-Out” signaling by preventing RhoA and β1 Integrin activation. Am J Physiol Renal Physiol. 2006; 291(5): F995-1004.

?

Contact

Division of Nephrology, Department of Medicine,

The Third Affiliated Hospital of Sun Yat-sen University

# 600 Tianhe Street, Guangzhou, Guangdong, China, 510630

E-mail: elizapeng01@hotmail.com

Phone: 8620-85252865

?